Key facts
- Medmo’s last known valuation is $21.7M (Aug 2021).
- It has raised $34.0M; the latest was Later Stage VC ($15.0M) in Oct 2025.
- Notable investors include Gaingels, Lerer Hippeau, C2 Ventures, Cooper Square Ventures, Covera Health — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Medmo
- ·The full record, as it builds
Funding rounds
No funding rounds for Medmo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medmo
Developer of a digital healthcare platform intended for medical imaging and scanning services. The company's platform offers a variety of scan types, including magnetic resonance imaging, computed tomography scan, mammogram, X-ray, ultrasound, breast magnetic resonance imaging, dual-energy X-ray absorptiometry, positron emission tomography-computed tomography, and nuclear scans, enabling doctors to close the loop on medical imaging and reduce overhead costs.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2017
- Employees
- 50
- Website
- medmo.com/
- Ownership
- Privately Held (backing)
Medmo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medmo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medmo in its N-PORT filings yet. We sweep new filings monthly.